Your browser doesn't support javascript.
loading
Somatic mutation distributions in cancer genomes vary with three-dimensional chromatin structure.
Akdemir, Kadir C; Le, Victoria T; Kim, Justin M; Killcoyne, Sarah; King, Devin A; Lin, Ya-Ping; Tian, Yanyan; Inoue, Akira; Amin, Samirkumar B; Robinson, Frederick S; Nimmakayalu, Manjunath; Herrera, Rafael E; Lynn, Erica J; Chan, Kin; Seth, Sahil; Klimczak, Leszek J; Gerstung, Moritz; Gordenin, Dmitry A; O'Brien, John; Li, Lei; Deribe, Yonathan Lissanu; Verhaak, Roel G; Campbell, Peter J; Fitzgerald, Rebecca; Morrison, Ashby J; Dixon, Jesse R; Andrew Futreal, P.
Afiliação
  • Akdemir KC; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. kcakedemir@mdanderson.org.
  • Le VT; Salk Institute for Biological Studies, La Jolla, CA, USA.
  • Kim JM; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Killcoyne S; Division of Biology and Medicine, Brown University, Providence, RI, USA.
  • King DA; MRC Cancer Unit, Hutchison/MRC Research Center, University of Cambridge, Cambridge, UK.
  • Lin YP; European Molecular Biology Laboratory, European Bioinformatics Institute, Hinxton, UK.
  • Tian Y; Department of Biology, Stanford University, Stanford, CA, USA.
  • Inoue A; Department of Ophthalmology and Visual Sciences, McGovern Medical School, The University of Texas Health Sciences Center at Houston, Houston, TX, USA.
  • Amin SB; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Robinson FS; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Nimmakayalu M; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Herrera RE; The Jackson Laboratory for Genomic Medicine, Farmington, CT, USA.
  • Lynn EJ; Translational Research to Advance Therapeutics and Innovation in Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Chan K; Graduate Program in Diagnostic Genetics and Genomics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Seth S; Department of Biology, Stanford University, Stanford, CA, USA.
  • Klimczak LJ; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Gerstung M; Genome Integrity and Structural Biology Laboratory, National Institute of Environmental Health Sciences, US National Institutes of Health, Durham, NC, USA.
  • Gordenin DA; Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, Ontario, Canada.
  • O'Brien J; Translational Research to Advance Therapeutics and Innovation in Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Li L; UT Health Graduate School of Biomedical Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Deribe YL; Integrative Bioinformatics Support Group, National Institute of Environmental Health Sciences, US National Institutes of Health, Durham, NC, USA.
  • Verhaak RG; European Molecular Biology Laboratory, European Bioinformatics Institute, Hinxton, UK.
  • Campbell PJ; Genome Integrity and Structural Biology Laboratory, National Institute of Environmental Health Sciences, US National Institutes of Health, Durham, NC, USA.
  • Fitzgerald R; Department of Ophthalmology and Visual Sciences, McGovern Medical School, The University of Texas Health Sciences Center at Houston, Houston, TX, USA.
  • Morrison AJ; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Dixon JR; Life Science Institute, Zhejiiang University, Hangzhou, China.
  • Andrew Futreal P; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Nat Genet ; 52(11): 1178-1188, 2020 11.
Article em En | MEDLINE | ID: mdl-33020667
ABSTRACT
Somatic mutations in driver genes may ultimately lead to the development of cancer. Understanding how somatic mutations accumulate in cancer genomes and the underlying factors that generate somatic mutations is therefore crucial for developing novel therapeutic strategies. To understand the interplay between spatial genome organization and specific mutational processes, we studied 3,000 tumor-normal-pair whole-genome datasets from 42 different human cancer types. Our analyses reveal that the change in somatic mutational load in cancer genomes is co-localized with topologically-associating-domain boundaries. Domain boundaries constitute a better proxy to track mutational load change than replication timing measurements. We show that different mutational processes lead to distinct somatic mutation distributions where certain processes generate mutations in active domains, and others generate mutations in inactive domains. Overall, the interplay between three-dimensional genome organization and active mutational processes has a substantial influence on the large-scale mutation-rate variations observed in human cancers.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Cromatina / Genoma Humano / Mutação / Neoplasias Limite: Female / Humans / Male Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Cromatina / Genoma Humano / Mutação / Neoplasias Limite: Female / Humans / Male Idioma: En Ano de publicação: 2020 Tipo de documento: Article